xml version="1.0" encoding="UTF-8"?


L\_2018029EN.01000801.xml


| | | | |
| --- | --- | --- | --- |
| 1.2.2018 | EN | Official Journal of the European Union | L 29/8 |

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/155

of 31 January 2018

amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [(1)](#ntr1-L_2018029EN.01000801-E0001), and in particular Article 19, thereof,

Whereas:

| | |
| --- | --- |
| (1) | Commission Implementing Regulation (EU) No 686/2012 [(2)](#ntr2-L_2018029EN.01000801-E0002) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 1 January 2022 and 31 December 2024 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation. |

| | |
| --- | --- |
| (2) | In view of the length of the evaluation process for active substances and the recent notification by the United Kingdom pursuant to Article 50 of the Treaty on European Union [(3)](#ntr3-L_2018029EN.01000801-E0003), it is necessary to re-allocate the evaluation of the active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 for which the United Kingdom is the rapporteur Member State or the co-rapporteur Member State, and for which no supplementary dossier has yet been submitted. The active substances concerned are aluminium ammonium sulphate, azoxystrobin, bupirimate, carbetamide, chlormequat, ethylene, fenbuconazole, fluopicolide, fluquinconazole, flutriafol, garlic extract, metazachlor, myclobutanil, paclobutrazol, pepper, plant oils/citronella oil, propaquizafop, quizalofop-p-ethyl, quizalofop-p-tefuryl, tri-allate and urea. |

| | |
| --- | --- |
| (3) | That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States. |

| | |
| --- | --- |
| (4) | This Regulation should enter into force as soon as possible given that the deadline for the submission of the supplementary dossier for some of the active substances concerned is on 28 February 2018. |

| | |
| --- | --- |
| (5) | Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly. |

| | |
| --- | --- |
| (6) | The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 31 January 2018.

For the Commission

The President

Jean-Claude JUNCKER

---

[(1)](#ntc1-L_2018029EN.01000801-E0001)  
[OJ L 309, 24.11.2009, p. 1](http://publications.europa.eu/resource/oj/JOL_2009_309_R_TOC).

[(2)](#ntc2-L_2018029EN.01000801-E0002)  Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances ([OJ L 200, 27.7.2012, p. 5](http://publications.europa.eu/resource/oj/JOL_2012_200_R_TOC)).

[(3)](#ntc3-L_2018029EN.01000801-E0003)  
[OJ C 326, 26.10.2012, p. 13](http://publications.europa.eu/resource/oj/JOC_2012_326_R_TOC).

---

ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (1) | In Part B, the entries corresponding to active substances Aluminium ammonium sulphate, Azoxystrobin, Bupirimate, Carbetamide, Chlormequat, Ethylene, Fenbuconazole, Fluopicolide, Fluquinconazole, Flutriafol, Garlic extract, Metazachlor, Myclobutanil, Paclobutrazol, Pepper, Plant oils/Citronella oil, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Tri-allate and Urea are replaced by the following corresponding entries: | | | | | --- | --- | --- | | Active substance | Rapporteur Member State | Co-rapporteur Member State | | ‘Aluminium ammonium sulphate | IE | PT’ | | ‘Azoxystrobin | AT | NO’ | | ‘Bupirimate | NL | PL’ | | ‘Carbetamide | SE | BE’ | | ‘Chlormequat | AT | IT’ | | ‘Ethylene | NL | ES’ | | ‘Fenbuconazole | SI | AT’ | | ‘Fluopicolide | AT | ES’ | | ‘Fluquinconazole | CZ | SK’ | | ‘Flutriafol | SK | CZ’ | | ‘Garlic extract | IE | DK’ | | ‘Metazachlor | NL | PT’ | | ‘Myclobutanil | AT | ES’ | | ‘Paclobutrazol | AT | RO’ | | ‘Pepper | BE | IE’ | | ‘Plant oils/Citronella oil | FR | CZ’ | | ‘Propaquizafop | AT | EE’ | | ‘Quizalofop-P-ethyl | FI | SE’ | | ‘Quizalofop-P-tefuryl | HR | AT’ | | ‘Tri-allate | NL | CZ’ | | ‘Urea | EL | FI’ | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (2) | The following Part C is added: ‘ PART C ALLOCATION OF THE EVALUATION OF ACTIVE SUBSTANCES WHOSE APPROVAL EXPIRES AFTER 31 DECEMBER 2021 AND NOT LATER THAN 31 DECEMBER 2024 | | | | | --- | --- | --- | | Active substance | Rapporteur Member State | Co-rapporteur Member State | | 1,4-Dimethylnaphthalene | AT | PL | | Acequinocyl | DE | NL | | Adoxophyes orana GV strain BV-0001 | DE | FR | | Ametoctradin | DE | NL | | Aminopyralid | FI | DK | | Amisulbrom | EL | FI | | Ascorbic acid | NL | FR | | Aureobasidium pullulans (strains DSM 14940 and DSM 14941) | AT | DE | | Bacillus firmus I-1582 | FR | DK | | Bacillus pumilus QST 2808 | IT | NL | | Benalaxyl-M | PT | IT | | Benzovindiflupyr | FR | AT | | Bixafen | CZ | BE | | Candida oleophila strain O | SI | DE | | Chlorantraniliprole | IE | DE | | Cyflumetofen | ES | AT | | Disodium phosphonate | FR | EL | | Emamectin | NL | SI | | Esfenvalerate | AT | PT | | Eugenol | ES | EL | | Fenpyrazamine | LV | LT | | Flubendiamide | EL | AT | | Flumetralin | HU | EL | | Fluopyram | AT | HR | | Fluxapyroxad | FR | EL | | Geraniol | ES | EL | | Halosulfuron methyl | IT | PL | | Helicoverpa armigera nucleopolyhedrovirus (HearNPV) | EE | FR | | Ipconazole | BE | FR | | Isopyrazam | NO | EL | | lambda-Cyhalothrin | SE | FR | | Maltodextrin | IE | FR | | Mandipropamid | AT | PT | | Metaflumizone | SE | EL | | Metam (incl. -potassium and -sodium) | BE | ES | | Metobromuron | FR | NO | | Metsulfuron-methyl | DK | SE | | Orange oil | FR | CZ | | Paecilomyces fumosoroseus strain Fe9901 | PL | NL | | Penflufen | PL | IE | | Penthiopyrad | SE | CZ | | Phosphane | ES | DE | | Potassium phosphonates (formerly potassium phosphite) | FR | EL | | Prosulfuron | FR | SK | | Pseudomonas sp. Strain DSMZ 13134 | NL | BG | | Pyridalyl | NL | BE | | Pyriofenone | LV | EL | | Pyroxsulam | DK | FI | | S-Abscisic acid | NL | DK | | Sedaxane | FR | AT | | Sodium silver thiosulphate | NL | LV | | Spinetoram | HR | ES | | Spiromesifen | IT | AT | | Spirotetramat | AT | NO | | Spodoptera littoralis nucleopolyhedrovirus | EE | FR | | Streptomyces lydicus WYEC 108 | NL | DE | | Tembotrione | AT | FR | | Thiencarbazone | FR | EL | | Thymol | ES | EL | | Trichoderma asperellum (strain T34) | SE | IT | | Trichoderma atroviride strain I-1237 | IT | SK | | Valifenalate (formerly Valiphenal) | HU | SI | | Zucchini Yellow Mosaik Virus, weak strain | DK | AT’ | |

---